PuSH - Publikationsserver des Helmholtz Zentrums München

Nakanishi, T.* ; Pigazzini, S.* ; Degenhardt, F.* ; Cordioli, M.* ; Butler-Laporte, G.* ; Maya-Miles, D.* ; Bujanda, L.* ; Bouysran, Y.* ; Niemi, M.E.* ; Palom, A.* ; Ellinghaus, D.* ; Khan, A.* ; Martínez-Bueno, M.* ; Rolker, S.* ; Amitrano, S.* ; Roade Tato, L.* ; Fava, F.* ; Spinner, C.D.* ; Prati, D.* ; Bernardo, D.* ; Garcia, F.* ; Darcis, G.* ; Fernandez-Cadenas, I.* ; Holter, J.C.* ; Banales, J.M.* ; Frithiof, R.* ; Kiryluk, K.* ; Duga, S.* ; Asselta, R.* ; Pereira, A.C.* ; Romero-Gómez, M.* ; Nafría-Jiménez, B.* ; Hov, J.R.* ; Migeotte, I.* ; Renieri, A.* ; Planas, A.M.* ; Ludwig, K.U.* ; Buti, M.* ; Rahmouni, S.* ; Alarcón-Riquelme, M.E.* ; Schulte, E.C. ; Franke, A.* ; Karlsen, T.H.* ; Valenti, L.* ; Zeberg, H.* ; Richards, J.B.* ; Ganna, A.*

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality.

J. Clin. Invest. 131:e152386 (2021)
Verlagsversion Postprint Forschungsdaten DOI PMC
BACKGROUND: There is considerable variability in COVID-19 outcomes amongst younger adults-and some of this variation may be due to genetic predisposition. METHODS: We combined individual level data from 13,888 COVID-19 patients (N=7,185 hospitalized) from 17 cohorts in nine countries to assess the association of the major common COVID-19 genetic risk factor (chromosome 3 locus tagged by rs10490770) with mortality, COVID-19-related complications and laboratory values. We next performed meta-analyses using FinnGen and the Columbia University COVID-19 Biobank. RESULTS: We found that rs10490770 risk allele carriers experienced an increased risk of all-cause mortality (HR 1.4, 95%CI 1.2-1.7). Risk allele carriers had increased odds of several COVID-19 complications: severe respiratory failure (OR 2.1, 95%CI 1.6-2.6), venous thromboembolism (OR 1.7, 95%CI 1.2-2.4), and hepatic injury (OR 1.5, 95%CI 1.2-2.0). Risk allele carriers ≤60 years had higher odds of death or severe respiratory failure (OR 2.7, 95%CI 1.8-3.9) compared to those >60 years (OR 1.5, 95%CI 1.2-1.8, interaction-p=0.038). Amongst individuals ≤60 years who died or experienced severe respiratory failure, 32.3% were risk variant carriers, compared to 13.9% of those not experiencing these outcomes. The genetic risk improved the prediction of death or severe respiratory failure similarly to, or better than, most established clinical risk factors. CONCLUSIONS: The major common COVID-19 genetic risk factor is associated with increased risks of morbidity and mortality, which are more pronounced amongst individuals ≤60 years. The effect was similar in magnitude and more common than most established clinical risk factors, suggesting potential implications for future clinical risk management.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
14.808
0.000
5
12
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Covid-19 ; Genetic Variation ; Genetics; Vaccine
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 0021-9738
e-ISSN 1558-8238
Quellenangaben Band: 131, Heft: 23, Seiten: , Artikelnummer: e152386 Supplement: ,
Verlag American Society of Clinical Investigation
Verlagsort 2015 Manchester Rd, Ann Arbor, Mi 48104 Usa
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-502700-003
Förderungen Amyndas Pharmaceuticals
PubMed ID 34597274
Erfassungsdatum 2021-11-24